SLNSW-The cyclin-dependent kinase 4/6 inhibitor palboci...-TN_cdi_proquest_miscellaneous_1751215637

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

Full title: The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

Author/creator: Finn, Richard S, MD, Crown, John P, Prof, Lang, Istvan, MD, Boer, Katalin, MD, Bondarenko, Igor M, Prof, Kulyk, Sergey O, MD, Ettl, Johannes, MD, Patel, Ravindranath, MD, Pinter, Tamas, MD, Schmidt, Marcus, MD, Shparyk, Yaroslav, MD, Thummala, Anu R, MD, Voytko, Nataliya L, MD, Fowst, Camilla, MD, Huang, Xin, PhD, Kim, Sindy T, BS, Randolph, Sophia, MD, Slamon, Dennis J, Prof.

Call Numbers:

Record Identifier: TN_cdi_proquest_miscellaneous_1751215637

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215637

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

    Record identifier

    TN_cdi_proquest_miscellaneous_1751215637

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215637

    Share

    The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215637

    The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

    Full title

    The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

    Author / Creator

    Finn, Richard S, MD ; Crown, John P, Prof ; Lang, Istvan, MD ; Boer, Katalin, MD ; Bondarenko, Igor M, Prof ; Kulyk, Sergey O, MD ; Ettl, Johannes, MD ; Patel, Ravindranath, MD ; Pinter, Tamas, MD ; Schmidt, Marcus, MD ; Shparyk, Yaroslav, MD ; Thummala, Anu R, MD ; Voytko, Nataliya L, MD ; Fowst, Camilla, MD ; Huang, Xin, PhD ; Kim, Sindy T, BS ; Randolph, Sophia, MD ; Slamon, Dennis J, Prof

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2015, Vol.16 (1), p.25-35

    Record Identifier

    TN_cdi_proquest_miscellaneous_1751215637

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Administration, Oral Aged Antimitotic agents Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Aromatase Inhibitors - administration & dosage Biomarkers, Tumor - analysis Biomarkers, Tumor - genetics Blood Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - enzymology Breast Neoplasms - genetics Breast Neoplasms - pathology Cancer Cancer therapies Cardiovascular disease Care and treatment Cell cycle Cyclin D1 - genetics Cyclin-Dependent Kinase 4 - antagonists & inhibitors Cyclin-Dependent Kinase 4 - metabolism Cyclin-Dependent Kinase 6 - antagonists & inhibitors Cyclin-Dependent Kinase 6 - metabolism Cyclin-Dependent Kinase Inhibitor p16 - genetics Disease-Free Survival Drug Administration Schedule Drug dosages Estrogen Europe Female Fractures Gene amplification Hematology, Oncology and Palliative Medicine Humans Intention to Treat Analysis Middle Aged Molecular Targeted Therapy Nitriles - administration & dosage North America Oncology, Experimental Pain Phosphotransferases Piperazines - administration & dosage Postmenopause Proportional Hazards Models Protein Kinase Inhibitors - administration & dosage Pyridines - administration & dosage Receptor, ErbB-2 - analysis Receptor, ErbB-2 - genetics Receptors, Estrogen - analysis Regulation Republic of Korea South Africa Time Factors Treatment Outcome Triazoles - administration & dosage Womens health

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_miscellaneous_1751215637

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215637

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections